uniQure N.V. Ordinary Shares vs Riot Platforms Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $21.51 (market cap $1.45B), while Riot Platforms Inc trades at $14.48 (market cap $5.66B). The key difference: Riot Platforms Inc is far larger — about 3.9× uniQure N.V. Ordinary Shares's market cap, and Riot Platforms Inc is more actively traded (21,816,889 versus 3,323,243). Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Riot Platforms Inc for 16 Days on average.
| QURE | RIOT | |
|---|---|---|
Market Cap | $1.45B | $5.66B |
Volume | 3,323,243 | 21,816,889 |
Sector | Health | Financials |
52-Week High | $70.59 | $28.67 |
52-Week Low | $9.03 | $11.83 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $707.46M | $6.07B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RIOT trades at $16.67, up 1.21% today, while showing bearish technical signals with 13 of 13 moving averages indicating sell signals. The company reported significant losses with a net income margin of -196.28% in 2026 and has missed earnings expectations for three consecutive quarters. However, analyst sentiment remains overwhelmingly positive with 94.74% buy ratings and a $31.64 consensus price target, reflecting optimism about the company's strategic shift toward data center operations and AI power capacity.
RIOT faces substantial fundamental challenges with persistent losses and negative cash flow, but the company's pivot to data center landlord strategy with $9.8 billion in contracted lease revenue through 2048 provides long-term revenue visibility. The stock offers significant upside potential if management can execute the business transition successfully, though investors must weigh the high valuation multiples against ongoing profitability concerns and execution risks in the competitive AI infrastructure market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →